Importantly, as many cancers exist near the threshold of metabolic cytotoxicity, where even moderate enhancements in cellular metabolism are sufficient to cause homeostatic disequilibrium (8), the oxidative synergism demonstrated by the TRPC1-PEMF-DOX axis may be exploited to selectively induce cancer-specific metabolic catastrophe (Figure 2). The gene discussed is TRPC1; the disease is cancer.